GE HealthCare: Q4 EPS up 23%
(CercleFinance.com) - GE HealthCare reports Q4 2024 adjusted EPS that is up almost 23% to $1.
45, with an adjusted operating margin up 2.6 points to 18.7%, seeing the benefits of productivity gains and volume effects.
At $5.3bn, the medical technology group's revenues rose 2% on both a gross and organic basis, with 6% organic growth in orders enabling a book-to-bill ratio at 1.09.
Achieving FY 2024 adjusted EPS of $4.49, adjusted operating margin of 16.3% and organic revenue growth of 1%, it is targeting 2025 target ranges of $4.61-$4.75, 16.7%-16.8% and 2%-3% respectively.
Copyright (c) 2025 CercleFinance.com. All rights reserved.
45, with an adjusted operating margin up 2.6 points to 18.7%, seeing the benefits of productivity gains and volume effects.
At $5.3bn, the medical technology group's revenues rose 2% on both a gross and organic basis, with 6% organic growth in orders enabling a book-to-bill ratio at 1.09.
Achieving FY 2024 adjusted EPS of $4.49, adjusted operating margin of 16.3% and organic revenue growth of 1%, it is targeting 2025 target ranges of $4.61-$4.75, 16.7%-16.8% and 2%-3% respectively.
Copyright (c) 2025 CercleFinance.com. All rights reserved.